About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.09 (-3.43%)
KURANASDAQKura Oncology Inc
Kura Oncology Inc share price
KURA price activity
Last Price
$12.090
Change (24hr)
-0.43 USD (-3.43%)
Volume
2.17M
Volume (4w avg)
-
Open
$12.50
Day Range
$11.99 - $12.61
Previous Close
$12.52
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
KURA price performance
Delayed
09 Sep, 8:00 pm GMT+0
KURA Market Signals